Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50–59 years

KE Schmader, MJ Levin, JW Gnann Jr… - Clinical infectious …, 2012 - academic.oup.com
(See the Editorial Commentary by Li et al, on pages 929–30 .) Background. Herpes zoster (HZ)
adversely affects individuals aged 50–59, but vaccine efficacy has not been assessed in …

Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy

KE Schmader - The Clinical journal of pain, 2002 - journals.lww.com
Objective This article reviews the prevalence, risk factors, natural history, and impact on quality
of life of painful diabetic neuropathy (PDN) and postherpetic neuralgia (PHN). Discussion …

[HTML][HTML] Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

…, DA Revicki, M Rothman, KE Schmader… - The journal of pain, 2008 - Elsevier
A consensus meeting was convened by the Initiative on Methods, Measurement, and Pain
Assessment in Clinical Trials (IMMPACT) to provide recommendations for interpreting clinical …

A method for assessing drug therapy appropriateness

JT Hanlon, KE Schmader, GP Samsa… - Journal of clinical …, 1992 - Elsevier
This study evaluated the reliability of a new medication appropriateness index. Using the
index, independent assessments were made of chronic medications taken by 10 ambulatory, …

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

…, C Miaskowski, SN Raja, ASC Rice, KE Schmader… - Mayo Clinic …, 2010 - Elsevier
The Neuropathic Pain Special Interest Group of the International Association for the Study of
Pain recently sponsored the development of evidence-based guidelines for the …

Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations

…, MB Max, M Saltarelli, KE Schmader… - Archives of …, 2003 - jamanetwork.com
Chronic neuropathic pain, caused by lesions in the peripheral or central nervous system,
comes in many forms. We describe current approaches to the diagnosis and assessment of …

Appropriate prescribing in elderly people: how well can it be measured and optimised?

A Spinewine, KE Schmader, N Barber, C Hughes… - The Lancet, 2007 - thelancet.com
Prescription of medicines is a fundamental component of the care of elderly people, and
optimisation of drug prescribing for this group of patients has become an important public-health …

Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly

KE Schmader, JT Hanlon, CF Pieper, R Sloane… - The American journal of …, 2004 - Elsevier
PURPOSE: To determine if inpatient or outpatient geriatric evaluation and management, as
compared with usual care, reduces adverse drug reactions and suboptimal prescribing in …

Recommendations for the management of herpes zoster

…, MC Rowbotham, KE Schmader… - Clinical infectious …, 2007 - academic.oup.com
The objective of this article is to provide evidence-based recommendations for the management
of patients with herpes zoster (HZ) that take into account clinical efficacy, adverse effects…

An interdisciplinary expert consensus statement on assessment of pain in older persons

…, SJ Lieber, D Lussier, KE Schmader… - The Clinical journal …, 2007 - journals.lww.com
This paper represents an expert-based consensus statement on pain assessment among
older adults. It is intended to provide recommendations that will be useful for both researchers …